Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors

• Main Authors: Yuchun Niu (Author), Anqi Lin (Author), Peng Luo (Author), Weiliang Zhu (Author), Ting Wei (Author), Ruixiang Tang (Author), Linlang Guo (Author), Jian Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundImmune checkpoint inhibitors (ICIs) are an important treatment modality that must be considered for patients with lung adenocarcinoma (LUAD). However, ICIs are effective only in some of these patients. Therefore, identifying biomarkers that accurately predict the prognosis of patients with...